A nonprofit founded to address a pressing U.S. health-care problem by manufacturing much-needed drugs that have fallen into short supply, or that are too expensive, will start out with a different approach: buying the drugs from pharmaceutical companies.
McKesson Corp., one of the largest U.S. drug distributors, sent pharmacies prescription opioids that had been removed from their bottles and replaced with over-the-counter painkillers, the Food and Drug Administration says.
Concerns about quality control and data integrity have focused on companies in India and China, where more and more ingredients used in medicine for the U.S. are being made. But those concerns aren’t limited to overseas factories, according to a year-long investigation into FDA’s regulation of the generic-drug industry.
U.S. and Chinese officials are set to begin trade negotiations on Monday in the hope of reaching a deal during a 90-day truce between President Donald Trump and Xi Jinping.